Phytocannabinoids in neurologic, neuropsychiatric, inflammatory, pain, cardiometabolic, hepatic, renal, and neoplastic disorders: Pharmacology, clinical evidence, and translational perspectives

Aggregator

07 Nov 2026 0 comments

Phytocannabinoids are pharmacologically diverse constituents of Cannabis sativa whose actions go beyond canonical cannabinoid receptors. Δ9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are best characterized, while cannabigerol, cannabidivarin, tetrahydrocannabivarin, cannabichromene, cannabinol, and related compounds are emerging candidates. This review integrates molecular pharmacology, pharmacokinetics, safety, and therapeutic evidence across neurologic, neuropsychiatric, inflammatory,...